EP 0712310 A1 19960522 - USE OF TUMOR NECROSIS FACTOR INHIBITORS TOGETHER WITH ANTIVIRAL AGENTS AND THERAPEUTIC COMPOSITIONS THEREOF AGAINST HIV INFECTION
Title (en)
USE OF TUMOR NECROSIS FACTOR INHIBITORS TOGETHER WITH ANTIVIRAL AGENTS AND THERAPEUTIC COMPOSITIONS THEREOF AGAINST HIV INFECTION
Title (de)
VERWENDUNG VON TUMORNEKROSEFAKTORINHIBITOREN ZUSAMMEN MIT ANTIVIRALEN MITTELN UND THERAPEUTISCHE ZUSAMMENSETZUNG DIESE ENTHALTEND GEGEN HIV-INFEKTIONEN
Title (fr)
UTILISATION D'INHIBITEURS DU FACTEUR DE NECROSE DES TUMEURS AVEC DES AGENTS ANTIVIRAUX ET COMPOSITIONS THERAPEUTIQUES DE CEUX-CI CONTRE L'INFECTION A VIH
Publication
Application
Priority
- US 9408741 W 19940803
- US 10175293 A 19930804
Abstract (en)
[origin: WO9504525A2] A pharmaceutical composition comprising: (a) a tumor necrosis factor inhibitor; (b) a compound selected from the group consisting of reverse transcriptase inhibitor, protease inhibitor, a gene inhibitor, myristoylation inhibitor, cell-virus binding inhibitor, LTR promoter site inhibitor, ribosome inactivators, platelet aggregation inhibitor and prophylactic and therapeutic HIV vaccine, and (c) a pharmaceutical inert nontoxic carrier are described.
IPC 1-7
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/445 (2006.01); A61K 31/52 (2006.01)
CPC (source: EP)
A61K 31/70 (2013.01)
Citation (search report)
See references of WO 9504525A2
Designated contracting state (EPC)
AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9504525 A2 19950216; WO 9504525 A3 19950601; AU 7376394 A 19950228; EP 0712310 A1 19960522
DOCDB simple family (application)
US 9408741 W 19940803; AU 7376394 A 19940803; EP 94922777 A 19940803